J. John

Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer

Sanket, R. Sabarinathan, D. Kelkar, 2022, medRxiv.

PIK3CA-mutations in breast cancer

C. Thomssen, J. Buchmann, V. Hanf, 2022, Breast Cancer Research and Treatment.

Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients

D. Bethmann, C. Thomssen, J. Buchmann, 2022, Diagnostics.

Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping

I. Grosse, D. Bethmann, C. Thomssen, 2021, Breast Care.

Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients

T. Stiewe, C. Thomssen, J. Buchmann, 2019, Oncotarget.

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

S. Wiemann, T. Beißbarth, C. Thomssen, 2017, Breast Cancer Research.